1[1]Tani K,Azuma M,Nakazaki Y,et al.Phase Ⅰ study of autologous tumor vaccines transduced with the GM-CSF gene in four patients with stageⅣ renal cell cancer in Japan:clinical and immunological findings.Mol Ther,2004,10(4):799-816. 被引量：1
2[2]Soiffer R,Hodi FS,Haluska F,et al.Vaccination with irradiated,autologous melanoma cells engineered to secrete granulocytemacrophage colony-stimulating factor by adenoviral-mediated gene transfer augments antitumor immunity in patients with metastatic melanoma.J Clin Oncol,2003,21(17):3343-3350. 被引量：1
3[3]Nemunaitis J,Jahan T,Ross H,et al.Phase 1/2 trial of autologous tumor mixed with an allogeneic GVAX vaccine in advanced-stage non-small-cell lung cancer.Cancer Gene Ther,2006,13(6):555-562. 被引量：1
4[4]Jaffee EM,Hruban RH,Biedrzycki B,et al.Novel allogeneic granulocyte-macrophagu colony-stimulating factor-secreting tumor vaccine for pancreatic cancer:a phase 1 trial of safety and immune activation.J Clin Oncol,2001,19(1):145-156. 被引量：1
5[5]Small EJ,Sacks N,Nemunaitis J,et al.Cnranulocyte macrophage colony-stimulating factor-secreting allogeneic cellular immunotherapy for hormone-refractory prostate cancer.Clin Cancer Res,2007,13(13):3883-3891. 被引量：1
6[6]Thomas AM,Santarsiero LM,Lutz ER,et al.Mesothelin-specific CD8(+) T cell responses provide evidence of in vivo cross-priming by antigen-presenting cells in vaccinated pancreatic cancer patients.J Exp Meal,2004,200(3):297-306. 被引量：1
7[7]Bubley GJ,Carducci M,Dahut W,et al.Eligibility and response guidelines for phase Ⅱ clinical trials in androgen-independent prostate cancer:recommendations from the Prostate-Specific Antigen Working Group.J Clin Oncol,1999,17(11)3461-3467. 被引量：1
8[8]Salgia R,Lynch T,Skarin A,et al.Vaccination with irradiated autologous tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor augments antitamor immunity in some patients with metastatic non-small-cell lung carcinoma.J Clin Oncol,2003,21(4):624-630. 被引量：1
9[9]Soiffer R,Hodi FS,Haluska F,et al.Vaccination with irradiated,autologous melanoma cells engineered to secrete granulocytemacrophage colony-stimulating factor by adenoviral-mediated gene transfer augments antitumor immunity in patients with metastatic melanoma.J Clin Oncol,2003,21(17):3343-3350. 被引量：1
10[10]Nemanaltis J,Sterman D,Jablons D,et al.Granulocyte-macrophage colony-stimulating factor gene-modified autologous tumor vaccines in non-small-cell lung cancer.J Natl Cancer Ⅰ,2004,96(4):326-331. 被引量：1
